Generation of Mouse Small Intestinal Epithelial Cell Lines That Allow the Analysis of Specific Innate Immune Functions

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Schwerk, Johannes ^a   Köster, Mario ^a   Hauser, Hansjörg ^a   Rohde, Manfred ^a   Fulde, Marcus ^b   Hornef, Mathias W ^b   May, Tobias ^c  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c InSCREENeX GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERFERON; INTERFERON TYPE III; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRIC RESISTANCE; ELECTRON MICROSCOPY; EPITHELIUM CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; INNATE IMMUNITY; INTESTINE BRUSH BORDER; INTESTINE CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLARIZATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TIGHT JUNCTION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; BACTERIA; BIOLOGICAL MARKERS; CELL LINE; CELL POLARITY; CELL PROLIFERATION; EMBRYO, MAMMALIAN; IMMUNITY, INNATE; INTERFERON TYPE I; INTESTINAL MUCOSA; INTESTINE, SMALL; MICE; PRIMARY CELL CULTURE; VIRUSES;

EID: 84881104036     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072700     Document Type: Article

References (47)

1. Pott J, Hornef M, (2012) Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep 13: 684-698. doi:10.1038/embor.2012.96. PubMed: 22801555.
2. Abreu MT, (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10: 131-144. doi:10.1038/nri2707. PubMed: 20098461.
3. Bjerknes M, Cheng H, (1981) Methods for the isolation of intact epithelium from the mouse intestine. Anat Rec 199: 565-574. doi:10.1002/ar.1091990412. PubMed: 7270915.
4. Cano-Gauci DF, Lualdi JC, Ouellette AJ, Brady G, Iscove NN, et al. (1993) In vitro cDNA amplification from individual intestinal crypts: a novel approach to the study of differential gene expression along the crypt-villus axis. Exp Cell Res 208: 344-349. doi:10.1006/excr.1993.1255. PubMed: 7690709.
5. Lotz M, Gütle D, Walther S, Ménard S, Bogdan C, et al. (2006) Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 203: 973-984. doi:10.1084/jem.20050625. PubMed: 16606665.
6. Fogh J, (1975) Human tumor cells in vitro. Plenum Press.
7. Pinto M, Robine-Leon S, Appay M-D, Kedinger M, Triadou N, et al. (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47: 323-330.
8. Bens M, Bogdanova A, Cluzeaud F, Miquerol L, Kerneis S, et al. (1996) Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. Am J Physiol 270: C1666-C1674. PubMed: 8764149.
9. Cohn SM, Simon TC, Roth KA, Birkenmeier EH, Gordon JI, (1992) Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium. J Cell Biol 119: 27-44. doi:10.1083/jcb.119.1.27. PubMed: 1527171.
10. El Marjou F, Janssen K-P, Chang BH-J, Li M, Hindie V, et al. (2004) Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis (New York, NY: 200039:: 186-193. doi:10.1002/gene.20042. PubMed: 15282745.
11. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, et al. (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265. doi:10.1038/nature07935. PubMed: 19329995.
12. Pulverer JE, Rand U, Lienenklaus S, Kugel D, Zietara N, et al. (2010) Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol 84: 8626-8638. doi:10.1128/JVI.00303-10. PubMed: 20573823.
13. Pott J, Stockinger S, Torow N, Smoczek A, Lindner C, et al. (2012) Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLOS Pathog 8: e1002670. doi:10.1371/journal.ppat.1002670. PubMed: 22570612.
14. Rothen-Rutishauser B, Braun a, Günthert M, Wunderli-Allenspach H (2000) Formation of multilayers in the caco-2 cell culture model: a confocal laser scanning microscopy study. Pharmaceutical research 17: 460-465.
15. Kamiyama E, Sugiyama D, Nakai D, Miura S, Okazaki O, (2009) Culture period-dependent change of function and expression of ATP-binding cassette transporters in Caco-2 cells. Drug Metab Dispos Biol Fate Chem 37: 1956-1962. doi:10.1124/dmd.109.027490. PubMed: 19505989.
16. Wang N, Wang Y, Li P, Peng W, Xie T, et al. (2009) The Bioavailability of Hepatoprotective Flavoniods in Hypericum Japonicum Extract. J Bioanal Biomed 01: 033-038. doi:10.4172/1948-593X.1000007.
17. Buzza MS, Netzel-Arnett S, Shea-Donohue T, Zhao A, Lin C-Y, et al. (2010) Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci U S A 107: 4200-4205. doi:10.1073/pnas.0903923107. PubMed: 20142489.
18. Deferme S, Annaert P, Augustijns P, (2008) In Vitro Screening Models to Assess and Metabolism. In: Ehrhardt C, Kim K-J, eds. Drug Absorption. Studies: pp. 182-215. doi:10.1007/978-0-387-74901-3.
19. Mineo H, Hara H, Shigematsu N, Okuhara Y, Tomita F, (2002) Melibiose. Difructose Anhydride III and Difructose Anhydride IV Enhance Net Calcium Absorption in Rat Small and Large Intestinal Epithelium by Increasing the Passage of Tight Junctions In Vitro. The Journal of Nutrition 132: 3394-3399.
20. Elankumaran S, Rockemann D, Samal SK, (2006) Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 80: 7522-7534. doi:10.1128/JVI.00241-06. PubMed: 16840332.
21. Krishnamurthy S, Takimoto T, Scroggs RA, Portner A, (2006) Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines. J Virol 80: 5145-5155. doi:10.1128/JVI.02618-05. PubMed: 16698995.
22. Kawai T, Akira S, (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137. doi:10.1038/ni1303. PubMed: 16424890.
23. Decker T, Müller M, Stockinger S, (2005) The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 5: 675-687. doi:10.1038/nri1684. PubMed: 16110316.
24. Trinchieri G, (2010) Type I interferon: friend or foe? J Exp Med 207. doi:10.1084/jem.20101664.
25. Ito Y, Nagai Y, Maeno K, (1982) Interferon Production in Mouse Spleen Cells and Mouse Fibroblasts (L Cells) Stimulated by Various Strains of Newcastle Disease Virus. J Gen Virol 62: 349-352. doi:10.1099/0022-1317-62-2-349. PubMed: 6183397.
26. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA, (2004) Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med 200: 527-533. doi:10.1084/jem.20040976. PubMed: 15302899.
27. O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, et al. (2004) Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 200: 437-445. doi:10.1084/jem.20040712. PubMed: 15302901.
28. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, et al. (2012) Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 13: 954-962. doi:10.1038/ni.2397. PubMed: 22922364.
29. Freudenberg MA, Merlin T, Kalis C, Chvatchko Y, Stübig H, et al. (2002) Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling. J Immunol (Baltimore, Md: 1950169:: 1665-1668. PubMed: 12165484.
30. Kernbauer E, Maier V, Stoiber D, Strobl B, Schneckenleithner C, et al. (2012) Conditional. Stat 1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection. PLoS pathogens 8: e1002763. doi:10.1371/journal.ppat.1002763.
31. Eglen R, Reisine T, (2011) Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev Technol 9: 108-124. doi:10.1089/adt.2010.0305. PubMed: 21186936.
32. Cheng K-C, Li C, Uss AS, (2008) Prediction of oral drug absorption in humans--from cultured cell lines and experimental animals. Expert Opin Drug Metab Toxicol 4: 581-590. doi:10.1517/17425255.4.5.581. PubMed: 18484916.
33. Turner JR, (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809. doi:10.1038/nri2653. PubMed: 19855405.
34. Rangarajan A, Hong SJ, Gifford A, Weinberg RA, (2004) Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6: 171-183. doi:10.1016/j.ccr.2004.07.009. PubMed: 15324700.
35. Feng N, Kim B, Fenaux M, Nguyen H, Vo P, et al. (2008) Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J Virol 82: 7578-7590. doi:10.1128/JVI.00391-08. PubMed: 18495762.
36. Pott J, Mahlakõiv T, Mordstein M, Duerr CU, Michiels T, et al. (2011) IFN-{lambda} determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108: 7944-7949. doi:10.1073/pnas.1100552108. PubMed: 21518880.
37. Bierne H, Travier L, Mahlakõiv T, Tailleux L, Subtil A, et al. (2012) Activation of Type III Interferon Genes by Pathogenic Bacteria in Infected Epithelial Cells and Mouse Placenta. PLOS ONE 7: e39080. doi:10.1371/journal.pone.0039080. PubMed: 22720036.
38. Sen A, Rothenberg ME, Mukherjee G, Feng N, Kalisky T, et al. (2012) Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proc Natl Acad Sci U S A 109: 20667-20672. doi:10.1073/pnas.1212188109. PubMed: 23188796.
39. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115: 695-702. doi:10.1172/JCI22996. PubMed: 15765149.
40. Wirtz S, Neurath MF, (2005) Illuminating the role of type I IFNs in colitis. J Clin Invest 115: 586-588. doi:10.1172/JCI24518. PubMed: 15765141.
41. Kugel D, Pulverer JE, Köster M, Hauser H, Staeheli P, (2011) Novel nonviral bioassays for mouse type I and type III interferon. J Interferon Cytokine Res Off J International Society For Interferon Cytokine Res 31: 345-349. doi:10.1089/jir.2010.0079. PubMed: 21138377.
42. Samuelsson CV, Lienenklaus S, Müller PP, Zawatzky R, Hauser H, et al. (2005) Transformation of mouse fibroblasts alters the induction pattern of type I IFNs after virus infection. Biochem Biophys Res Commun 335: 584-589. doi:10.1016/j.bbrc.2005.07.124. PubMed: 16091286.
43. Ahuja D, Sáenz-Robles MT, Pipas JM, (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24: 7729-7745. doi:10.1038/sj.onc.1209046. PubMed: 16299533.
44. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880. PubMed: 9811723.
45. May T, Eccleston L, Herrmann S, Hauser H, Goncalves J, et al. (2008) Bimodal and hysteretic expression in mammalian cells from a synthetic gene circuit. PLOS ONE 3: e2372. doi:10.1371/journal.pone.0002372. PubMed: 18523635.
46. Katz J, Sambandam V, Wu JH, (2000) Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect Immun 68: 1441-1449. doi:10.1128/IAI.68.3.1441-1449.2000. PubMed: 10678958.
47. Spurr AR, (1969) A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 26: 31-43. doi:10.1016/S0022-5320(69)90033-1. PubMed: 4887011.